Clinical Trial Update: Clinical Trial of Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris) [Phase 1, Phase 2]

View source ↗

Summary

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. reports completion of a Phase 1/2 trial evaluating a quadrivalent recombinant norovirus vaccine produced in Pic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroenteritis

Drugs mentioned

• Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris) (Norovirus vaccine)

Snippet

Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | Conditions: Acute Gastroenteritis | Phase 1, Phase 2 | Status: COMPLETED